Literature DB >> 23977622

Radial artery as a second arterial graft in the elderly and both sexes.

Robert H Habib1, Nadeem E Abou-Arraj, Thomas A Schwann.   

Abstract

BACKGROUND: Use of multiple arterial grafts for surgical coronary revascularization remains limited in scope worldwide, and is disproportionately low in two growing segments of coronary artery disease patients-women and the elderly. While a prevailing practice, this trend is not supported by objective data. This report discusses two recent reports that support the liberal use of the radial artery (RA) as a second arterial conduit, in the elderly and irrespective of sex, instead of the conventional operation based on a single internal thoracic artery (ITA) with additional vein grafts.
METHODS: From 1996 to 2007, 6,384 patients underwent primary, non-salvage emergency coronary artery bypass grafting with at least 2 complete grafts (including one ITA graft) were included in the present analysis. Those with bilateral ITA, ITA-only grafts, or concomitant valve/aortic surgery were excluded. 2,605 patients aged 70 or greater were further included in a subsequent analysis. Patients were further matched on propensity score models based on ITA/RA versus ITA/saphenous vein (SV) grafts.
RESULTS: 69% of all included patients were male. Propensity models yielded 1,416 ITA/RA and ITA/SV matched pairs in men and 567 pairs in women. Operative mortality was similar for both graft combinations in men and women, while late mortality was significantly lower for ITA/RA subcohorts in both sexes. Matched Kaplan-Meier cumulative mortality was significantly better for ITA/RA irrespective of sex (men: risk reduction (RR) =0.65, P<0.001; women: RR=0.75, P=0.045). In patients aged 70 years or older, operative death was essentially identical for ITA/RA vs. ITA/SV (2.31% vs. 2.31%; P=0.880). Patients undergoing ITA/RA grafting had significantly better unadjusted 12-year survival. In 480 elderly matched pairs, cumulative mortality at 1, 5, and 10 years was significantly better for the ITA/RA cohort.
CONCLUSION: The discussed data showed a clinically significant improvement in intermediate (1-5 years) and late (>5 years) survival with multiple arterial grafts in female and male patients and in the elderly. The latter was true for both the septuagenarian and octogenarian subgroups. Importantly, the choice of the RA as the second arterial conduit seems to be associated with low associated perioperative risks, and avoids the potential for sternal healing complications due to bilateral ITA dissection in certain patients.

Entities:  

Keywords:  Coronary artery bypass grafting (CABG); Kaplan-Meier survival; gender; propensity matching

Year:  2013        PMID: 23977622      PMCID: PMC3741884          DOI: 10.3978/j.issn.2225-319X.2013.06.05

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  17 in total

1.  Radial artery conduits improve long-term survival after coronary artery bypass grafting.

Authors:  Robert F Tranbaugh; Kamellia R Dimitrova; Patricia Friedmann; Charles M Geller; Loren J Harris; Paul Stelzer; Bertram Cohen; Darryl M Hoffman
Journal:  Ann Thorac Surg       Date:  2010-10       Impact factor: 4.330

2.  Comparison of late coronary artery bypass graft survival effects of radial artery versus saphenous vein grafting in male and female patients.

Authors:  Thomas A Schwann; Milo Engoren; Mark Bonnell; Christopher Clancy; Robert H Habib
Journal:  Ann Thorac Surg       Date:  2012-07-07       Impact factor: 4.330

3.  Contemporary coronary graft patency: 5-year observational data from a randomized trial of conduits.

Authors:  Philip A R Hayward; Brian F Buxton
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

4.  Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up.

Authors:  Peter Collins; Carolyn M Webb; Chee F Chong; Neil E Moat
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

5.  Techniques and benefits of multiple internal mammary artery bypass at 20 years of follow-up.

Authors:  J Scott Rankin; Robert H Tuttle; Andrew S Wechsler; Tracey L Teichmann; Donald D Glower; Robert M Califf
Journal:  Ann Thorac Surg       Date:  2007-03       Impact factor: 4.330

6.  The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years.

Authors:  Bruce W Lytle; Eugene H Blackstone; Joseph F Sabik; Penny Houghtaling; Floyd D Loop; Delos M Cosgrove
Journal:  Ann Thorac Surg       Date:  2004-12       Impact factor: 4.330

7.  Thirty-year follow-up defines survival benefit for second internal mammary artery in propensity-matched groups.

Authors:  Paul A Kurlansky; Ernest A Traad; Malcolm J Dorman; David L Galbut; Melinda Zucker; George Ebra
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

8.  Late outcomes after radial artery versus saphenous vein grafting during reoperative coronary artery bypass surgery.

Authors:  Anoar Zacharias; Thomas A Schwann; Christopher J Riordan; Samuel J Durham; Aamir S Shah; Milo Engoren; Robert H Habib
Journal:  J Thorac Cardiovasc Surg       Date:  2009-10-09       Impact factor: 5.209

9.  Improved survival with radial artery versus vein conduits in coronary bypass surgery with left internal thoracic artery to left anterior descending artery grafting.

Authors:  Anoar Zacharias; Robert H Habib; Thomas A Schwann; Christopher J Riordan; Samuel J Durham; Aamir Shah
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

10.  Sequential radial artery grafts for multivessel coronary artery bypass graft surgery: 10-year survival and angiography results.

Authors:  Thomas A Schwann; Anoar Zacharias; Christopher J Riordan; Samuel J Durham; Aamir S Shah; Robert H Habib
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

View more
  2 in total

1.  [Cardiac surgery in the elderly].

Authors:  B Wiegmann; I Ismail; A Haverich
Journal:  Chirurg       Date:  2017-02       Impact factor: 0.955

Review 2.  Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?

Authors:  M S Fernández-Alfonso; M Gil-Ortega; I Aranguez; D Souza; M Dreifaldt; B Somoza; M R Dashwood
Journal:  Br J Pharmacol       Date:  2017-03-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.